ACTA1 and neoplasm: The genetic expression cluster of reactive stromal signature, described by the Australian Ovarian Cancer Study Group (AOCS), predicts a poorer prognosis and correlates with high levels of desmoplasia and Alpha Smooth Muscle Actin (αSMA) expression by tumor-associated myofibroblasts and pericytes [3,4].